The present invention relates to disulfide masked prodrug compounds of formula I, compositions and methods that are amenable to bioactivation by a reducing agent such as glutathione: W—P(V)LG (Formula I), wherein P(V)LG is a pentavalent phosphorus leaving group; and W is: where...